122 related articles for article (PubMed ID: 15355566)
1. Osteopontin-deficiency suppresses growth of B16 melanoma cells implanted in bone and osteoclastogenesis in co-cultures.
Ohyama Y; Nemoto H; Rittling S; Tsuji K; Amagasa T; Denhardt DT; Nifuji A; Noda M
J Bone Miner Res; 2004 Oct; 19(10):1706-11. PubMed ID: 15355566
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues.
Nemoto H; Rittling SR; Yoshitake H; Furuya K; Amagasa T; Tsuji K; Nifuji A; Denhardt DT; Noda M
J Bone Miner Res; 2001 Apr; 16(4):652-9. PubMed ID: 11315992
[TBL] [Abstract][Full Text] [Related]
3. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
4. High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6.
Chen GL; Luo Y; Eriksson D; Meng X; Qian C; Bäuerle T; Chen XX; Schett G; Bozec A
Oncotarget; 2016 May; 7(18):26653-69. PubMed ID: 27049717
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy.
Yamate T; Mocharla H; Taguchi Y; Igietseme JU; Manolagas SC; Abe E
Endocrinology; 1997 Jul; 138(7):3047-55. PubMed ID: 9202251
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone.
Asou Y; Rittling SR; Yoshitake H; Tsuji K; Shinomiya K; Nifuji A; Denhardt DT; Noda M
Endocrinology; 2001 Mar; 142(3):1325-32. PubMed ID: 11181551
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin is required for mechanical stress-dependent signals to bone marrow cells.
Ishijima M; Tsuji K; Rittling SR; Yamashita T; Kurosawa H; Denhardt DT; Nifuji A; Ezura Y; Noda M
J Endocrinol; 2007 May; 193(2):235-43. PubMed ID: 17470514
[TBL] [Abstract][Full Text] [Related]
8. Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration.
Hayashi C; Rittling S; Hayata T; Amagasa T; Denhardt D; Ezura Y; Nakashima K; Noda M
J Cell Biochem; 2007 Jul; 101(4):979-86. PubMed ID: 17390343
[TBL] [Abstract][Full Text] [Related]
9. Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone.
Natasha T; Kuhn M; Kelly O; Rittling SR
Am J Pathol; 2006 Feb; 168(2):551-61. PubMed ID: 16436669
[TBL] [Abstract][Full Text] [Related]
10. Histochemical evidence of osteoclastic degradation of extracellular matrix in osteolytic metastasis originating from human lung small carcinoma (SBC-5) cells.
Li M; Amizuka N; Takeuchi K; Freitas PH; Kawano Y; Hoshino M; Oda K; Nozawa-Inoue K; Maeda T
Microsc Res Tech; 2006 Feb; 69(2):73-83. PubMed ID: 16456838
[TBL] [Abstract][Full Text] [Related]
11. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of bone marrow stromal cell lines that support osteoclastogenesis.
Matsumoto HN; Tamura M; Denhardt DT; Obinata M; Noda M
Endocrinology; 1995 Sep; 136(9):4084-91. PubMed ID: 7544276
[TBL] [Abstract][Full Text] [Related]
13. The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway.
Akatsu T; Ono K; Katayama Y; Tamura T; Nishikawa M; Kugai N; Yamamoto M; Nagata N
J Bone Miner Res; 1998 Mar; 13(3):400-8. PubMed ID: 9525340
[TBL] [Abstract][Full Text] [Related]
14. Magnesium deficiency results in an increased formation of osteoclasts.
Belluci MM; Schoenmaker T; Rossa-Junior C; Orrico SR; de Vries TJ; Everts V
J Nutr Biochem; 2013 Aug; 24(8):1488-98. PubMed ID: 23517915
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation.
Kitahara K; Ishijima M; Rittling SR; Tsuji K; Kurosawa H; Nifuji A; Denhardt DT; Noda M
Endocrinology; 2003 May; 144(5):2132-40. PubMed ID: 12697722
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells.
Takita M; Inada M; Maruyama T; Miyaura C
FEBS Lett; 2007 Feb; 581(3):565-71. PubMed ID: 17254571
[TBL] [Abstract][Full Text] [Related]
17. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro.
Chikatsu N; Takeuchi Y; Tamura Y; Fukumoto S; Yano K; Tsuda E; Ogata E; Fujita T
Biochem Biophys Res Commun; 2000 Jan; 267(2):632-7. PubMed ID: 10631114
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.
Abu-Amer Y; Ross FP; Edwards J; Teitelbaum SL
J Clin Invest; 1997 Sep; 100(6):1557-65. PubMed ID: 9294124
[TBL] [Abstract][Full Text] [Related]
19. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
Nagata N; Kitaura H; Yoshida N; Nakayama K
Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
